NCT07193069 Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
| NCT ID | NCT07193069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier de Saint-Denis |
| Condition | Drug Overdose |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-11 |
| Primary Completion | 2026-04-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-04-11 with a primary completion date of 2026-04-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Admission to an intensive care unit (ICU) due to acute drug poisoning * Documented exposure to either: * Metformin alone * Metformin in combination with dapagliflozin Exclusion Criteria: * Patients under 18 years of age * No exposure to metformin * Exposure to dapagliflozin without metformin
Frequently Asked Questions
Who can join the NCT07193069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Drug Overdose. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07193069 currently recruiting?
Yes, NCT07193069 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Hospitalier de Saint-Denis to inquire about joining.
Where is the NCT07193069 trial being conducted?
This trial is being conducted at Saint-Denis, France.
Who is sponsoring the NCT07193069 clinical trial?
NCT07193069 is sponsored by Centre Hospitalier de Saint-Denis. The trial plans to enroll 50 participants.